ClinVar Miner

Submissions for variant NM_024675.4(PALB2):c.3366C>T (p.Asp1122=)

gnomAD frequency: 0.00001  dbSNP: rs373783514
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000123342 SCV000166661 likely benign Familial cancer of breast 2025-01-14 criteria provided, single submitter clinical testing
Ambry Genetics RCV000164965 SCV000215657 likely benign Hereditary cancer-predisposing syndrome 2014-07-29 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Counsyl RCV000123342 SCV000488091 likely benign Familial cancer of breast 2015-12-23 criteria provided, single submitter clinical testing
GeneDx RCV000430555 SCV000524582 likely benign not specified 2017-08-08 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Color Diagnostics, LLC DBA Color Health RCV000164965 SCV000690915 likely benign Hereditary cancer-predisposing syndrome 2017-08-20 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV000123342 SCV004019632 benign Familial cancer of breast 2023-03-31 criteria provided, single submitter clinical testing This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing.
CeGaT Center for Human Genetics Tuebingen RCV003422008 SCV004141319 likely benign not provided 2023-10-01 criteria provided, single submitter clinical testing PALB2: BP4, BP7
PreventionGenetics, part of Exact Sciences RCV004530059 SCV004740693 likely benign PALB2-related disorder 2019-04-08 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.